Intranasal Ketamine Versus Intramuscular Ketamine for Procedural Sedation in Pediatric Patients
- Registration Number
- NCT01170247
- Lead Sponsor
- University of Iowa
- Brief Summary
The purpose of this study is to determine if intranasal ketamine is equally as effective and safe as intramuscular ketamine for procedural sedation in pediatric patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
- pediatric patients age 2 to 17 years old
- have a laceration of 4 cm on the face or 7 cm on the remainder of the body
- Require procedural sedation to repair the laceration
Exclusion Criteria
- Patients with abnormal nasal physiology which would not allow for adequate medication delivery
- Unable to have a guardian present to consent on their behalf
- Allergy to ketamine
- Significant cardiac history (myocardial ischemia, heart failure, arrhythmias)
- Presenting with a head injury associated with possible intracranial hypertension
- Pregnancy
- Lacerations that require repair from a consult service
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intranasal Ketamine Ketamine - Intramuscular Ketamine Ketamine -
- Primary Outcome Measures
Name Time Method Onset of Sedation Every 60 seconds through study completion Minutes it takes until the patient is cooperative enough for the procedure
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Iowa Hospitals and Clinics
🇺🇸Iowa City, Iowa, United States